AbbVie
ABBV
ABBV
3,122 hedge funds and large institutions have $196B invested in AbbVie in 2023 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,243 increasing their positions, 1,354 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,122
Holders Change
-31
Holders Change %
-0.98%
% of All Funds
49.97%
Holding in Top 10
301
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-13.01%
% of All Funds
4.82%
New
156
Increased
1,243
Reduced
1,354
Closed
117
Calls
$3.15B
Puts
$2.04B
Net Calls
+$1.11B
Net Calls Change
+$1.25B
Top Buyers
| 1 |
Charles Schwab
San Francisco,
California
|
$3.43B |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$1.21B |
| 3 |
Amundi
Paris,
France
|
$1.39B |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$25.6B |
| 5 |
Citadel Advisors
Miami,
Florida
|
$361M |
